Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DoubleLine Capital is an independent, employee-owned investment management firm founded in 2009 by Jeffrey Gundlach. The firm is widely recognized for its expertise in fixed-income asset management, particularly in mortgage-backed securities and global bond markets. Headquartered in Tampa, Florida, DoubleLine offers a variety of investment vehicles, including mutual funds, ETFs, and separate accounts for institutional and individual investors. While the firm manages significant assets across diverse sectors, it is a financial services provider and does not operate as a biotechnology or healthcare company. Its investment strategies are driven by a macro-thematic approach and rigorous fundamental analysis. The firm is well-known for its flagship Total Return Bond Fund and its leadership's influential market commentary.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DoubleLine Capital.